February 2019 - Page 408 of 474

NASDAQ Companies - February 6, 2019

CareDx to Participate in BTIG 6th Annual Medical Technology, Life Science Tools and Diagnostics Conference

BRISBANE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development […]

NASDAQ Companies - February 6, 2019

Zscaler to Host Second Quarter Fiscal 2019 Earnings Conference Call

Earnings Results to be released on Thursday, February 28, 2019, After the Close of the Market SAN JOSE, Calif., Feb. 06, […]

NASDAQ Companies - February 6, 2019

Fibrocell to Present at 21st Annual BIO CEO & Investor Conference

EXTON, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational […]

NASDAQ Companies - February 6, 2019

Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot

Efforts to Validate Saphyr for Digital Cytogenetics are Accelerating SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. […]

NASDAQ Companies - February 6, 2019

Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B

Results show a four-fold reduction in bleeding time for CB 2679d-GT and a three-fold improvement in clotting activity when compared […]

NASDAQ Companies - February 6, 2019

Alkaline Water Co Launches First Phase of A88 Infused Division to Consumers at Multiple Trade Shows

SCOTTSDALE, Ariz., Feb. 06, 2019 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER), a leading producer of premium […]

NASDAQ Companies - February 6, 2019

Aspen Group, Inc. Delivers 1,363 New Student Enrollments in Q3 FY’19, a 40% Increase Year-Over-Year

Pre-Licensure BSN Program Enrolled 97 Students in Quarter, as Night/Weekend Progam Launched in January NEW YORK, Feb. 06, 2019 (GLOBE […]

NASDAQ Companies - February 6, 2019

Fate Therapeutics Announces FDA Clearance of IND Application for World’s First Cell Therapy Derived from an Engineered Pluripotent Stem Cell

FT516 Off-the-Shelf NK Cell Cancer Immunotherapy Cleared for Clinical Investigation by FDA Product Candidate Derived from Clonal Master iPSC Line […]

NASDAQ Companies - February 6, 2019

New eSecurityPlanet.com Survey Shows Majority of Businesses Plan to Accelerate IT Security Spending and Hiring

Highly publicized data breaches, increasing vulnerabilities, and new privacy regulations globally are pushing companies to increase spending on trusted IT […]

NASDAQ Companies - February 6, 2019

Zogenix Submits New Drug Application to U.S. Food & Drug Administration and Marketing Authorization Application to European Medicines Agency for FINTEPLA® for the Treatment of Dravet Syndrome

EMERYVILLE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies, today […]